脑钠肽和肿瘤坏死因子—α在心力衰竭患者中的浓度变化及相关性(2)
 |
| 第1页 |
参见附件。
[2]Raine A E，Erne P，Burgisser E，et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure[J].N Engl J Med，1986，315(9)：533-537.
[3]Nakaoka H，Imataka K，Amano M，et al.Plasma levels of atrial na- triure ic factor in patients with congestive heart failure[J].N Engl J Med，1999，313(78)：892-893.
[4]Schiffrin E L，Taillefer R.Correlation of left ventricular ejection fraction and plasma atrial natriuretic peptide in congestive heart failure[J].N Engl J Med，1986，315(34)：765-766.
[5]Gottlieb S S，Kukin M L，Ahern D，et al.Prognostic importance of atrial natriuretic pepti-de in patients with chronic heart failure[J].J Am Coll Cardiol，2009，13(8)：1534-1539.
[6]Omland T，Aakvaag A，Bonarjee V V，et al.Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and longterm survival after acute myocardial infarction.Comparison with plasma atrial natriure- tic peptide and N- terminal proatrial natriuretic peptide[J].Circulation，1996，93(8)：1963-1969.
[7]Birkenfeld A L，Budziarek P，Boschmann M，et al.Atrial natriuretic peptide induces postpran- dial lipid oxidation in man[J].Diabetes，2008，193(67)：1673-1677.
[8]Liu S F，Malik A B.NF-kappa B activation as a pathological mechanism of septic shock and in- flammation[J].Am J Physiol Lung Cell Mol Physiol，2006，290(34)：622-645.
[9]Siednienko J，Jankowska E A，Banasiak W，et al.Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure[J].Int J Cardiol，2007，122(79)：111-116.
[10]Sharma R，Bolger A P，Rauchhaus M，et al.Cellular endotoxin desensitization in patients with severe chronic heart failure[J].Eur J Heart Fail，2005，7(6)：865-868.
(收稿日期：2012-12-11) (编辑：王春芸)
您现在查看是摘要介绍页，详见PDF附件。